Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

05. April 2024 09:00 ET | Quelle: IR-Med, Inc.

IR-MED’s PressureSafe™ Receives FDA Listing for the Indication of Decision Support Device for Pressure Injuries

Marks major milestone prior to launch in U.S. marketPressureSafe™ scanner and disposable pack both listed with FDAPressureSafe™ can support early detection of pressure injuries, potentially setting a...
13. September 2023 09:15 ET | Quelle: IR-Med, Inc.

IR-MED Appoints Richard Serbin, Esq. to its Advisory Board

Served as Chief FDA Counsel for Revlon and Johnson & Johnson, as a Board Member at Johnson & Johnson Development Corporation, that company’s strategic venture capital division, and as patent...
14. März 2023 09:00 ET | Quelle: IR-Med, Inc.

IR-Med to present at National Pressure Injury Advisory Panel 2023

The company’s PressureSafe device is being designed to reduce healthcare disparity in pressure injury detection and treatment Rosh Pina, Israel, March 14, 2023 (GLOBE NEWSWIRE) -- “IR-MED” or the...
16. November 2022 09:32 ET | Quelle: IR-Med, Inc.

IR-Med Announces Dr. David Dalton as Advisory Board member

Dr. Dalton brings decades of experience as a hall of fame CEO, entrepreneur, pharmaceutical executive and founder of over 40 companies Rosh Pinna, Israel, Nov. 16, 2022 (GLOBE NEWSWIRE) --...
12. August 2022 08:34 ET | Quelle: IR-Med, Inc.

IR-Med files Provisional Patent Application Covering Additional Features of its PressureSafe Device for Early Detection of Pressure Injuries

Rosh Pinna, Israel, Aug. 12, 2022 (GLOBE NEWSWIRE) -- (“IR-MED or the “Company”) (OTCQB:IRME), an innovative medical device company, developing non-invasive, real-time detection devices that utilize...